Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
Cancer Research and Treatment|January 17, 2012
A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal CarcinomatosisDong Hyun Lee, Sung Yong Oh, Yu Rim Lee, et al.
The Korean Journal of Internal Medicine|November 11, 2015
Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemiaHo Jin Lee, Dong Hyun Kim, Seul Lee, et al.
American Journal of Clinical Oncology|September 23, 2009
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancerByung Geun Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Investigational New Drugs|May 8, 2009
Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trialSung Yong Oh, Won Seog Kim, Dae Ho Lee, et al.
American Journal of Clinical Oncology|February 6, 2009
Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancerSung-Hyun Kim, Hyuk-Chan Kwon, Sung Yong Oh, et al.
Blood Advances|April 7, 2022
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphomaTycel Phillips, Henry Chan, Constantine S Tam, et al.
Cancer Science|April 20, 2010
Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancerHyuk-Chan Kwon, Sung Hyun Kim, Sung Yong Oh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 22, 2012
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapySeok-Hyun Kim, Gyeong-Won Lee, Min Jeong Lee, et al.
Cancer Research and Treatment|August 25, 2017
Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching AnalysisJun Ho Ji, Young Saing Kim, Inkeun Park, et al.
World Journal of Gastroenterology|September 25, 2012
Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patientsHyuk-Chan Kwon, Sung-Hyun Kim, Sung Yong Oh, et al.
Pageof 22